Sun Pharmaceutical Industries (NSE:SUNPHARMA, BOM:524715) said CRISIL removed the Rating Watch with Developing Implications status and reaffirmed the rating assigned to its long-term bank facilities at CRISIL AAA.
The outlook is stable, according to a Wednesday Indian bourse filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.